Skip to main content
Log in

The effect of aldosterone on glucose metabolism

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

There is an association of glucose intolerance and diabetes with primary aldosteronism, but the frequency and mechanisms are not clear. This paper reviews the possible mechanisms of impaired glucose metabolism in primary aldosteronism. Patients with primary aldosteronism can have impaired pancreatic insulin release and reduction in insulin sensitivity. These effects may be due to hypokalemia, but the evidence suggests other factors such as a direct impact of excess aldosterone on insulin action in contributing to the metabolic dysfunction. In general adrenal surgery in cases of aldosterone-producing adenoma will correct the metabolic abnormalities, but it is less sure if treatment with spironolactone in cases of idiopathic hyperplasia will correct impaired glucose tolerance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Conn JW, Knopf RF, Nesbit RM: Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 1964, 107:159–172. Classic paper on this subject.

    Article  PubMed  CAS  Google Scholar 

  2. Conn JW: Hypertension, the potassium ion and impaired carbohydrate tolerance. N Engl J Med 1965, 273:1135–1143.

    Article  PubMed  CAS  Google Scholar 

  3. Stern N, Tuck M: The adrenal cortex and mineralocorticoid hypertension. In Manual of Endocrinology and Metabolism. Edited by Lavin N. Philadelphia: Lippincott Williams & Wilkins; 2002:115–138.

    Google Scholar 

  4. Blumfeld JD, Sealy JE, Schlussel F, et al.: Diagnosis and treatment of primary aldosteronism. Ann Intern Med 1994, 121:877–885.

    Google Scholar 

  5. Ganguly A: Primary aldosteronism. N Engl J Med 1998, 339:1828–1834.

    Article  PubMed  CAS  Google Scholar 

  6. Irrony I: Correctable subsets of primary aldosteronism. Am J Hypertens 1990, 3:576–582.

    Google Scholar 

  7. Shimamoto K, Shiiki M, Ise T, et al.: Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism? J Hum Hypertens 1994, 10:755–759.

    Google Scholar 

  8. Shamiss A, Carroll J, Rosenthal T: Insulin resistance in secondary hypertension. Am J Hypertens 1992, 5:26–28.

    PubMed  CAS  Google Scholar 

  9. Škrha J, Šindelka G, Prázný M, et al.: Insulin action in primary aldosteronism [abstract]. Diabetologia 1997, 40(Suppl A):291.

    Google Scholar 

  10. Šindelka G, Widimský J, Haas T, et al.: Insulin action in primary aldosteronism before and after surgical or pharmacological treatment. Exp Clin Endocrinol Diabetes 2000, 108:21–25. This group has done the most careful clinical studies to characterize the mechanisms of metabolic dysfunction in primary aldosteronism.

    PubMed  Google Scholar 

  11. Widimský J, Strauch B, Šindelka G, Škrha J: Can primary hyperaldosteronism be considered a specific form of diabetes mellitus? Physiol Res 2001, 50:603–607.

    PubMed  Google Scholar 

  12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000, 23(Suppl 1):S4-S19.

    Google Scholar 

  13. Ishimori M, Takeda N, Okumura S, et al.: Increased insulin sensitivity in patients with aldosterone producing adenoma. Clin Endocrinol 1994, 41:433–438.

    CAS  Google Scholar 

  14. Rowe JW, Tobin JD, Rosa RM, Andres R: Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 1980, 29:498–502.

    Article  PubMed  CAS  Google Scholar 

  15. Saglid U, Anderson V, Andreasen PB: Glucose tolerance and insulin responsiveness in experimental potassium depletion. Acta Med Scand 1961, 169:243–251.

    Article  Google Scholar 

  16. Nestler JE, McClanahan MA: Diabetes and adrenal disease. Baillieres Clin Endocrinol Metab 1992, 4:829–847.

    Article  Google Scholar 

  17. Mani H, Takeda K, Kiyama M, et al.: A case of nephrotic syndrome with diabetes mellitus and primary aldosteronism. Nippon Jinzo Gakkai Shi 1999, 41:442–447.

    PubMed  CAS  Google Scholar 

  18. Ranade K, Wu KD, Risch N, et al.: Genetic variation in aldosterone synthase predicts plasma glucose levels. Proc Natl Acad Sci U S A 2001, 98:13219–13224.

    Article  PubMed  CAS  Google Scholar 

  19. Petrasek D, Jensen G, Tuck M, Stern N: In vitro effect of insulin on aldosterone production in rat zona glomerulosa cells. Life Sci 1992, 50:1781–1787.

    Article  PubMed  CAS  Google Scholar 

  20. Laverty G, Bjarnadottir S, Elrond VS, et al.: Aldosterone suppresses expression of an avian colonic sodium-glucose transporter. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1041-R1050.

    PubMed  CAS  Google Scholar 

  21. Campion J, Maestro B, Mata F, et al.: Inhibition by aldosterone of insulin receptor mRNA levels and insulin binding in U-937 human promonocytic cells. J Steroid Biochem Mol Biol 1999, 70:211–218.

    Article  PubMed  CAS  Google Scholar 

  22. Campion J, Maestro B, Molero N, et al.: Aldosterone impairs insulin responsiveness in U-937 human promonocytic cells via the downregulation of its own receptor. Cell Biochem Funct 2002, 20:237–245. These investigators present exciting data to show direct effects of aldosterone on the insulin receptor and insulin action.

    Article  PubMed  CAS  Google Scholar 

  23. Carranza MC, Torres A, Calle C, et al.: Diminucion en numero y en la afinidad de los insulina en el tejido adipso subcutaneo de un paciente con hyperaldosteronismo primero. Rev Clin Exp 1991, 188:414–417.

    CAS  Google Scholar 

  24. Campion J, Lahera V, Cachofiero V, et al.: In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess. Mol Cell Biochem 1998, 185:177–182.

    Article  PubMed  CAS  Google Scholar 

  25. Sauer J, Castren M, Hopfner U, et al.: Inhibition of lipopolysaccharide-induced monocyte interleuken-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid system. J Clin Endocrinol Metab 1996, 81:73–79.

    Article  PubMed  CAS  Google Scholar 

  26. Wantanabe Y, Akabayashi A, McWen BS: Adrenal steroid regulation of neuropeptide Y (NPY) mRNA differences between dentate and locus coruleus and arcuate nuclease. Mol Brain Res 1995, 28:135–140.

    Article  Google Scholar 

  27. Ahamad M, Medford RM: Evidence for the regulation of Na+K+-ATPase a1 gene expression through the interaction of aldosterone and CAMP-inducible transcriptional factors. Steroids 1995, 60:147–152.

    Article  Google Scholar 

  28. Silvestre JS: Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999, 99:2694–2699.

    PubMed  CAS  Google Scholar 

  29. Torpy DJ: Leptin levels are suppressed in primary aldosteronism. Horm Metab Res 1999, 31:533–536.

    Article  PubMed  CAS  Google Scholar 

  30. Haluzik M, Šindelka G, Widimský J, et al.: Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity. J Hum Hypertens 2002, 16:41–45.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corry, D.B., Tuck, M.L. The effect of aldosterone on glucose metabolism. Current Science Inc 5, 106–109 (2003). https://doi.org/10.1007/s11906-003-0065-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-003-0065-2

Keywords

Navigation